Headquartered in Japan as a global healthcare company and listed on one of the world’s major stock exchanges, we operate drug discovery, pharmaceutical development, biomaterial development, clinical studies, manufacturing, and sales in both the US and China.
Company Details
- Employees
- 9
- Address
- 2-2-2 Nihonbashi-Honcho, Nihonbashi-Honcho Ys Bldg. 3rd Floor,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Biotechnology, Pharmaceutical, Pirfenidone, Hydronidone, Targeted Protein Degradation, Japan, US, China.
- HQ
- Chuo-ku, Tokyo
Gni Group Ltd. Questions
Gni Group Ltd.'s website is https://www.gnipharma.com/english/
Gni Group Ltd.'s LinkedIn profile is https://jp.linkedin.com/company/gni-group-ltd
Gni Group Ltd. has
9 employees.
View email and phone details for 9
employees at Gni Group Ltd..
Gni Group Ltd.'s industry is
Pharmaceutical Manufacturing
Gni Group Ltd.'s top competitors are
Gyre Therapeutics,
株式会社ワンエイティ,
オープンハウス アメリカ不動産,
Impress Healthcare Ltd,
Catalyst Biosciences,
Galixir,
Alsanie,
Kuramae Creations,
Otera Stay,
Gyre Pharmaceuticals.
Gni Group Ltd.'s categories are Pharmaceutical Manufacturing
